Our mission is to create a contraceptive technology that renders hormonal birth control obsolete. We are addressing the millions of women that are demanding non-hormonal products with fewer side-effects to manage their fertility. Today, nearly 60 years after the first oral contraceptive pill was sold, most prescription birth control methods are variations on the same synthetic hormones. In collaboration with the Royal Institute of Technology in Stockholm, Sweden, we have developed a technology that reinforces the natural barrier properties of cervical mucus. The principle of the technology is to use topically-applied biopolymers to make cervical mucus impenetrable to sperm cells throughout the menstrual cycle. Our approach enables a potentially groundbreaking product that protects within a minute and for extended periods without the systemic side-effects known from hormonal contraceptives. In 2019 we raised $1.8M for pre-clinical development. Today we are incubated at the BioInnovation Institute, conveniently located in central Copenhagen, with access to state-of-the-art labs.